THE ALTERED LIPID AND PROTEIN METABOLISM OF PEDIATRIC PATIENTS WITH HIV INFECTIO

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 尽管高效抗逆转录病毒疗法（HAART）显著降低了艾滋病毒感染儿童的发病率和死亡率，但预期寿命的延长与一部分患者的一系列复杂的代谢紊乱有关。这些疾病包括生长障碍伴较低瘦体重（LBM）和血脂异常，一种以高胆固醇血症和高胆固醇血症为特征的综合征。虽然这些代谢紊乱的临床特征描述，其机制的基础是未知的。重要的是要描绘这些机制，以建立新的治疗儿童患者，因为生长障碍将导致发育迟缓和慢性血脂异常可能会加速发展为成年心血管疾病。在本项目中，我们计划测试以下假设：1）具有血脂异常的HIV感染患者的高脂血症是极低密度脂蛋白（VLDL）合成速率增加的结果，继发于禁食状态下更快的脂解速率，以及VLDL-和乳糜微粒-TG水解受损的结果，继发于进食状态下脂蛋白脂肪酶活性受损的结果，2）高胆固醇血症部分是由于胆固醇向肝脏的转运受损，这是由于高密度脂蛋白载脂蛋白A1（HDL-apoA 1）的可用性降低，3）富含多不饱和脂肪酸和单不饱和脂肪酸的低脂饮食将改善HIV感染的血脂异常受试者的高胆固醇血症和高胆固醇血症。 关于蛋白质代谢，我们假设4）HIV感染的儿童由于蛋白质催化剂上调导致净蛋白质合成不足而具有较低的LBM。为了验证这些假设，我们建议进行稳定同位素示踪实验，以实现以下具体目标：具体目标#1。 通过DEXA测定一组有血脂异常的HIV感染青少年和年轻成人的身体组成、血脂谱、空腹和进食状态下的血浆脂肪酸出现率、脂肪酸氧化、肝脂肪酸再酯化、HDL-apoA 1、VLDL-TG和-apoB-100的浓度和合成率以及脂蛋白脂酶活性，并与无血脂异常的对照组进行比较。 具体目标#2 比较由更大比例的单不饱和脂肪酸和多不饱和脂肪酸组成的低脂饮食（28%能量）与无饮食调整对HIV感染的血脂异常青少年中这些相同结局变量的影响。 具体目标#3 测量HIV感染的青春期前儿童与年龄和性别匹配的HIV暴露儿童的瘦体重（LBM）和蛋白质动力学，并确定饮食能量和蛋白质补充对HIV感染组LBM和蛋白质动力学的影响。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Although highly active anti-retroviral therapy (HAART) has markedly reduced the morbidity and mortality of HIV-infected children, the improved life expectancy is associated with a complex set of metabolic disorders in a subset of patients. These disorders include growth failure with lower lean body mass (LBM) and dyslipidemia, a syndrome characterized by hypertriglyceridemia and hypercholesterolemia. Although the clinical features of these metabolic derangements are described, their mechanistic underpinnings are unknown. It is important to delineate these mechanisms in order to establish new therapies for pediatric patients because growth failure will lead to stunting and chronic dyslipidemia may accelerate the progression to cardiovascular disease in adulthood. In this project we plan to test the following hypotheses: 1) the hypertriglyceridemia of HIV-infected patients with dyslipidemia is the result of an increased rate of very low density lipoprotein (VLDL) synthesis, secondary to a faster rate of lipolysis in the fasted state, and impaired hydrolysis of VLDL- and chylomicron-TG, secondary to impaired lipoprotein lipase activity in the fed state, 2) hypercholesterolemia is in part due to impaired cholesterol transport to the liver because of a reduction in the availability of high density lipoprotein apoprotein A1 (HDL-apoA1), 3) a lower fat diet rich in poly and mono-unsaturated fatty acids will improve the hypertriglyceridemia and hypercholesterolemia of HIV-infected dyslipidemic subjects. With respect to protein metabolism we hypothesize that 4) HIV-infected children have a lower LBM due to a deficit in net protein synthesis because of upregulated protein catabolism. To test these hypotheses we propose to conduct stable isotope tracer experiments to achieve the following specific aims: Specific aim #1. Measure body composition by DEXA, plasma lipid profile, plasma fatty acid appearance rate in the fasted and fed states, fatty acid oxidation, hepatic fatty acid re-esterification, the concentration and synthesis rates of HDL-apoA1, VLDL-TG and -apoB-100, and lipoprotein lipase activity in a group of HIV-infected adolescents and young adults with dyslipidemia versus a matched group without dyslipidemia. Specific aim #2. Compare the effects of a reduced fat diet (28% energy) comprised of a greater proportion of mono- and poly-unsaturated fatty acids versus no dietary modification on these same outcome variables in HIV-infected adolescents with dyslipidemia. Specific aim #3. Measure lean body mass (LBM) and protein kinetics in HIV-infected prepubertal children versus age-and gender-matched HIV-exposed children and determine the effect of dietary energy and protein supplementation on LBM and protein kinetics in the HIV-infected group.